Form 4: Vita Coco CEO's Spouse Donates 20,000 Shares
Statement of Changes in Beneficial Ownership
The spouse of Vita Coco Company CEO Martin Roper donated 20,000 shares of common stock for charitable purposes on November 25, 2025.
Summary
- Martin Roper, Chief Executive Officer and Director of Vita Coco Company, Inc. (COCO), reported a change in beneficial ownership.
- On November 25, 2025, Roper's spouse donated 20,000 shares of the company's common stock to a donor-advised fund for charitable purposes.
- Following this transaction, Roper directly owns 281,562 shares of common stock.
- Indirect ownership includes 41,200 shares by his spouse, 215,631 shares by the Christopher G. Roper Exempt Family Trust, 216,131 shares by the Peter S. Roper Exempt Family Trust, and 216,131 shares by the Thomas L. Roper Exempt Family Trust.
- Roper also holds various non-qualified stock options, including 579,670 options at an exercise price of $10.178 (fully vested), 40,950 options at $10.178 (fully vested), 298,507 options at $15 (vesting from November 27, 2022), 46,875 options at $16.91 (vesting from March 10, 2024), 62,743 options at $26.18 (vesting from March 4, 2025), and 70,715 options at $32.78 (vesting from March 3, 2026).
Sentiment
Score: 5
Explanation: The filing reports a charitable donation by the CEO's spouse, which is a personal transaction and generally neutral for the company's operational or financial performance. It does not indicate any significant positive or negative sentiment regarding the company itself.
Positives
- The charitable donation by the CEO's spouse demonstrates philanthropic engagement.
Negatives
- A reduction in indirect beneficial ownership by 20,000 shares, though for charitable purposes.
Related Party Transactions
- The spouse of the reporting person, a related party, donated 20,000 shares of common stock for charitable purposes.
Stakeholder Impact
- Minimal direct impact on shareholders, employees, customers, suppliers, or creditors as this is a personal charitable donation by a related party, not a company operational event.
Key Dates
| Date | Description |
|---|---|
| 2022-11-27 | Start of vesting for 298,507 non-qualified stock options with an exercise price of $15, vesting in four equal annual installments. |
| 2024-03-10 | Start of vesting for 46,875 non-qualified stock options with an exercise price of $16.91, vesting in four equal annual installments. |
| 2025-03-04 | Start of vesting for 62,743 non-qualified stock options with an exercise price of $26.18, vesting in four equal annual installments. |
| 2025-11-25 | Date of spouse's donation of 20,000 shares of common stock to a donor-advised fund for charitable purposes. |
| 2025-11-26 | Signature date of the reporting person's attorney-in-fact for the Form 4 filing. |
| 2026-03-03 | Start of vesting for 70,715 non-qualified stock options with an exercise price of $32.78, vesting in four equal annual installments. |
| 2029-09-19 | Expiration date for 579,670 fully vested non-qualified stock options with an exercise price of $10.178. |
| 2031-01-11 | Expiration date for 40,950 fully vested non-qualified stock options with an exercise price of $10.178. |
| 2031-10-21 | Expiration date for 298,507 non-qualified stock options with an exercise price of $15. |
| 2033-03-10 | Expiration date for 46,875 non-qualified stock options with an exercise price of $16.91. |
| 2034-03-04 | Expiration date for 62,743 non-qualified stock options with an exercise price of $26.18. |
| 2035-03-03 | Expiration date for 70,715 non-qualified stock options with an exercise price of $32.78. |
Keywords
Vita Coco, COCO, Martin Roper, SEC Form 4, Insider Transaction, Stock Donation, Beneficial Ownership, CEO, Director, Charitable Giving
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.